Based on 15 analysts giving stock ratings to Procept Biorobotics Corp in the past month.
In the current month, PRCT has received 4 Buy Ratings, 9 Hold Ratings, and 1 Sell Ratings. PRCT average Analyst price target in the last month is 24.571.
Based on analysts' estimates, PRCT EPS is projected to reach -0.250 in FY2026Q4, following reported EPS of -0.463 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.46, while Procept Biorobotics CorpPRCT's earnings per share (EPS) for the previous quarter was USD -0.47. EPS for the next quarter is expected at USD -0.25.